Mainly, cyanidin‐3‐O‐glucoside suppresses inflammation and the production of pro‐inflammatory cytokines (COX‐2, TNF‐α, and IL‐6) in colorectal and hepatocellular carcinoma and causes cell cycle inhibition and mitochondrial dysfunction in ovarian and cervical malignancies. This evidence concerns the gene IL6 and hepatocellular carcinoma.